Starting next year, Louisiana could require health insurance plans to cover prostate cancer screenings starting at age 40, ...
A Shropshire hospital trust says patients with prostate cancer are benefitting from greater survival rates thanks to a ...
Success in cancer care increasingly includes survivorship outcomes, emphasizing durable function and symptom control for patients cured and those with prolonged metastatic disease. Variable survival ...
By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...
In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and ...
A late-stage clinical biopharmaceutical company focused on immunotherapy for various cancers, SELLAS Life Sciences Group ...
A London-based doctor is raising awareness about the importance of getting tested for colorectal cancer, including among ...
A new wave of immuno-therapies is reshaping the fight against cancer, turning the body’s own immune system into a powerful ...
Although survival rates for acute myeloid leukemia (AML) continue to improve, many long-term survivors face persistent physical limitations, high rates of comorbidities, and suboptimal lifestyle ...
Colon cancer is one of the most common cancers in the U.S., with more than 100,000 cases diagnosed each year. But some people ...
(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Investigators sought to determine whether complementary and alternative medicine (CAM) affects survival in female patients with breast cancer.